The Academy of Managed Care Pharmacy (AMCP) is pleased to provide comments to the Food and Drug Administration (FDA) on the notice of revisions of postmarketing reporting requirements regarding discontinuance as related to drug shortages published in the Federal Register on December 19, 2011.
***Please see additional comments attached***
Attachments:
Academy of Managed Care Pharmacy (AMCP) - FDA - drug shortage discontinuance 2.2012
Title: Academy of Managed Care Pharmacy (AMCP) - FDA - drug shortage discontinuance 2.2012
Academy of Managed Care Pharmacy (AMCP) - Comment
This is comment on Rule
Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance
View Comment
Attachments:
Academy of Managed Care Pharmacy (AMCP) - FDA - drug shortage discontinuance 2.2012
Title:
Academy of Managed Care Pharmacy (AMCP) - FDA - drug shortage discontinuance 2.2012
Related Comments
View AllPublic Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0003
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0004
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0005
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0007
Feb 17,2012 11:59 PM ET
Public Submission Posted: 03/01/2012 ID: FDA-2011-N-0898-0009
Feb 17,2012 11:59 PM ET